Rozerowong 10/20 milligrams

Adult dose

This medication is administered once daily without regard to meals. The dosage range is 10/5 mg to 10/20 mg per day. The recommended starting dose is 10/5 mg per day. In patients requiring a greater reduction in LDL cholesterol, the dosage may be adjusted accordingly. After initiating treatment or adjusting the dose, it is recommended to check blood lipid levels at intervals of more than 4 weeks, and adjust the dosage accordingly, up to a maximum of 10/20 mg per day.

This medication has been reported to cause rare but serious muscular problems. If severe muscle pain or weakness symptoms occur, it is essential to consult a physician immediately. This medication should not be administered to patients with impaired liver function or certain muscle disorders. It should also not be used in patients with severely impaired kidney function, or in pregnant or breastfeeding women. Patients with a history of alcohol dependence or liver disease, elderly patients, and those with hypothyroidism should exercise extra caution while using this medication. Patients at high risk of myopathy should have their muscle enzyme levels checked thoroughly before and during treatment. During the use of this medication, regular liver function tests should be conducted, and if any abnormal symptoms regarding the liver appear, the use of the medication should be discontinued immediately. Additionally, this medication can interact with other drugs, so if there are any currently taken medications, it is imperative to inform the physician or pharmacist. Special caution is needed when combined with drugs that affect blood coagulation, certain antibiotics, antifungals, and immunosuppressants. Women of childbearing potential should use appropriate contraceptive methods while taking this medication, and if pregnancy is confirmed, the medication should be discontinued immediately. This medication has not been adequately studied for safety and efficacy in children; therefore, it is not recommended for use in the pediatric population. In the case of overdose, as there are no specific antidotes, appropriate treatment should be administered based on symptoms, and monitoring of liver function and muscle enzyme levels is necessary. Finally, this medication should be stored out of the reach of children and not transferred to other containers.

Serious side effects

Urticaria, severe swelling, chest tightness, difficulty breathing, cold sweats, pallor, severe rash with fever, blisters, peeling skin, pain in oral/eye mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough + fever, jaundice (skin or eyes turning yellow), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion of consciousness, visual disturbances, paralysis, significantly reduced urine output

Mild side effects

• Nasopharyngitis
• joint pain
• headache
• dizziness
• upper respiratory tract infection
• myalgia
• constipation
• nausea
• abdominal pain
• thrombocytopenia

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. The recommended storage temperature is between 1 and 30 degrees Celsius. Proper storage conditions will help maintain the effectiveness of the medication.

Appearance

White to almost white round film-coated tablets

Package unit

30 tablets (15 tablets/PTP × 2)